Skip to content
Biodatica
Start free

Investigator

Linda Mac Pherson Bradley

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · funded by NCI

Companies
3

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.2M

Summed across those awards.

First award
Aug 7, 2024

Latest Mar 10, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer

    $268k

    Mar 10, 2025NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11115362 (opens the source filing in a new tab)

  2. R21

    Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer

    $210k

    Mar 10, 2025NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11300256 (opens the source filing in a new tab)

  3. R01

    Rewiring T cell exhaustion with immune checkpoint blockade therapy

    $675k

    Aug 7, 2024NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11163378 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources